Insulin regulates Presenilin 1 localization via PI3K/Akt signaling.

Recently, insulin signaling has been highlighted in the pathology of Alzheimer's disease (AD). Although the association between insulin signaling and Tau pathology has been investigated in several studies, the interaction between insulin signaling and Presenilin 1 (PS1), a key molecule of amyloid beta (Abeta) pathology, has not been elucidated so ...
far. In this study, we demonstrated that insulin inhibited PS1 phosphorylation at serine residues (serine 353, 357) via phosphatidylinositol 3-kinase (PI3K)/Akt signal pathway and strengthened the trimeric complex of PS1/N-cadherin/beta-catenin, consequently relocalizing PS1 to the cell surface. Since our recent report suggests that PS1/N-cadherin/beta-catenin complex regulates Abeta production, it is likely that insulin signaling affects Abeta pathology by regulating PS1 localization.
Mesh Terms:
Animals, Cadherins, Cell Line, Tumor, Cells, Cultured, Cerebral Cortex, Dose-Response Relationship, Drug, Enzyme Inhibitors, Humans, Immunoprecipitation, Insulin, Mice, Models, Biological, Neuroblastoma, Neurons, Oncogene Protein v-akt, Phosphatidylinositol 3-Kinases, Phosphorylation, Presenilin-1, Protein Transport, Serine, Signal Transduction, Transfection
Neurosci. Lett.
Date: Oct. 15, 2010
Download Curated Data For This Publication
198399
Switch View:
  • Interactions 3